ProQR Therapeutics
PRQR • NASDAQ • Stock Fundamentals
ProQR Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Daniel Anton de Boer, with a market cap of $151.7M.
Market Cap$151.7M
Employees157.0
CEODaniel Anton de Boer
CountryNetherlands
Healthcare
Biotechnology
Most Recent EarningsMay 12, 2026 · 1 month 2 days agoQ1 2026
View reportNext EarningsAug 6, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
ProQR Therapeutics FAQ
Common questions about ProQR Therapeutics
ProQR Therapeutics (PRQR) has a market capitalization of $151.7M and trades on NASDAQ.
ProQR Therapeutics has approximately 157 employees.